Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant for prevention of postoperative nausea and vomiting
NCT00326248Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Jul 2006
- Countries
- 11
01
Overview
Phase 3, randomised, double-blind trial of casopitant in postoperative nausea and vomiting (PONV), sponsored by GSK. Primary endpoint: Proportion of subjects with no vomiting or retching at 24 hours. Started Mar 2006; status: completed.
02
Drugs
casopitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00326248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326248.